What role can bispecific antibodies play in cancer targeting? A hypothesis.

Abstract

Monoclonal antibodies (mAbs) are currently among the best remedies in the treatment of cancer disorders. Almost 12 anti-cancer therapeutic mAbs have been approved for clinical applications. Although mAbs have been found to target specific antigens, numerous impediments are emerged in cancer therapy by mAbs because of expression of a low level of the same… (More)
DOI: 10.1016/j.mehy.2013.03.022

Topics

Cite this paper

@article{Kafil2013WhatRC, title={What role can bispecific antibodies play in cancer targeting? A hypothesis.}, author={Vala Kafil and Behzad Baradaran and Yadollah Omidi}, journal={Medical hypotheses}, year={2013}, volume={81 1}, pages={44-6} }